Cell Therapy Research Webinar
Possessing access to a full picture of the cell therapy landscape to facilitate drug development is crucial. However, in such an extremely competitive and dynamic landscape, staying up-to-date on the latest cell therapy deals, company advancements, and drug and trial data can be challenging.
In this, first-of-its-kind, webinar, we were thrilled to present the most up-to-date insights to support efficiency and productivity by eliminating the noise and focusing on the information that matters most to you. Key aspects explored include:
The Deals Landscape – Analysing recent collaborations, partnerships, mergers, and acquisitions and what it means for the cell therapy space
The Drug and Trial Landscape – Reviewing current trends in therapeutic class, cell type, and disease indication
Upcoming Announcements – Evaluating future milestones for cell therapy in terms of clinical progression
Our Experts
Rachel East
House Speaker
Senior Lead Research Analyst
Beacon
Bertie MacArthur
Moderator
Account Manager
Beacon
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
